Everest Medicines Announces Successful Release of First Clinical Batch of Tumor-Associated Antigen Vaccine EVM14 at Jiashan Manufacturing Site
SHANGHAI, June 20, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today...
BOE's Green Eco-Forum Successfully Held, Joining Hands with Global Eco-Partners to Co-Create a Sustainable Future
BEIJING, May 15, 2025 /PRNewswire/ -- BOE successfully conducted the second edition of its exclusively-hosted "Define the Future Green Eco-Forum" on May 15 during Display Week 2025. Centered on the theme of "Green Development", the forum advocated...
Private Cellular Deployment Takes a Hit in U.S. Manufacturing, with Initial Private 5G Rollout Numbers Dipping by 11% Since 2024
Survey results show that U.S. manufacturing's interest in private cellular has plummeted NEW YORK, May 13, 2025 /PRNewswire/ -- Global technology intelligence firm ABI Research recently completed its 2025 Manufacturers' Technology Adoption &...